Insider · CIK 0001768369
Viola L Acoff
director
Files at CRS (CARPENTER TECHNOLOGY CORP). First filing Mar 6, 2025, latest Mar 6, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $807k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
CRS: CARPENTER TECHNOLOGY CORP
CRSOct 9, 2026 · close 385.81
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | CRSsell CARPENTER TECHNOLOGY CORP | $807k 4,000 shares | -100% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Unitsderivative | +361 | - | - | 22,107 | 4 d ago |
| Oct 6, 2026 | CRS CARPENTER TECHNOLOGY CORP | AGrant or award Director Stock Option (Right to Buy)derivative | +193 | - | - | 193 | 4 d ago |
| Mar 4, 2025 | CRS CARPENTER TECHNOLOGY CORP | MOption exercise Common Stock | +4,000 | $45.12 | $180k | 4,000 | Mar 6, 2025 |
| Mar 4, 2025 | CRS CARPENTER TECHNOLOGY CORP | SOpen-market sale Common Stock | -4,000 | $201.83 | $807k | 0 | Mar 6, 2025 |
| Mar 4, 2025 | CRS CARPENTER TECHNOLOGY CORP | MOption exercise Director Stock Option (Right to Buy)derivative | -4,000 | - | - | 0 | Mar 6, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.